What is the appropriate workup for a patient suspected of rhabdomyolysis?

Rhabdomyolysis Workup

Immediately measure creatine kinase (CK), comprehensive metabolic panel with electrolytes (especially potassium), urinalysis for myoglobinuria, and obtain an ECG to assess for hyperkalemia-related arrhythmias. 1

Essential Initial Laboratory Tests

The diagnostic workup begins with core tests that establish the diagnosis and identify life-threatening complications:

Diagnostic Confirmation

• Creatine kinase (CK): CK ≥5-10 times the upper limit of normal is diagnostic for rhabdomyolysis 1. This is the single most important test, though levels may not peak until 24-120 hours after the inciting event 2. At 9 hours post-injury, CK may still be rising significantly and not yet at maximum 2.
• Urinalysis: Look for myoglobinuria, indicated by brown or dark urine that is positive for blood without red blood cells present 1. Serum myoglobin can be detected earlier than CK but has a shorter half-life 3.

Life-Threatening Electrolyte Assessment

• Potassium: Check immediately and monitor closely, as hyperkalemia can precipitate cardiac arrhythmias and cardiac arrest 1. This is the most urgent electrolyte abnormality.
• Complete electrolyte panel: Include calcium (assess for hypocalcemia), phosphorus (assess for hyperphosphatemia), and magnesium 3, 1. These are common complications of rhabdomyolysis.
• Arterial blood gas: Assess for metabolic acidosis, which commonly occurs in severe rhabdomyolysis 3, 1.

Renal Function Monitoring

• Creatinine and BUN: Essential to monitor for acute kidney injury, the most serious systemic complication 1. Myoglobin-induced renal tubular obstruction can lead to acute kidney injury requiring dialysis 2.
• Comprehensive metabolic panel: Include glucose, calcium, and phosphorus 1.

Cardiac Assessment

• ECG: Perform immediately to assess for arrhythmias related to hyperkalemia 1. This is critical as hyperkalemia can cause sudden cardiac death.
• Cardiac troponin: Check in patients with severe rhabdomyolysis to rule out cardiac involvement 3, 1.

Additional Muscle Enzymes

Beyond CK, measure additional muscle enzymes that are commonly elevated:

• LDH, AST (SGOT), ALT (SGPT), and aldolase 2, 1. These help confirm muscle breakdown and assess for hepatic involvement.

Baseline Hematologic and Inflammatory Assessment

• Complete blood count with differential: Evaluate for infection or other systemic processes 2, 1.
• Coagulation studies: Assess for disseminated intravascular coagulation, which can complicate severe rhabdomyolysis 2, 3.
• Inflammatory markers (ESR and CRP): Evaluate for inflammatory processes 1.

Etiology-Specific Testing

The workup should be tailored based on clinical context:

For Drug-Induced or Metabolic Causes

• Thyroid function tests: Evaluate for hypothyroidism, which predisposes to statin-induced rhabdomyolysis 1.
• Liver function tests: Assess for hepatic involvement and distinguish between hepatocellular and other patterns of injury 2, 3.
• Medication review: Document all prescription medications, over-the-counter medications, herbal supplements (particularly red yeast rice containing lovastatin, creatine monohydrate, wormwood oil, licorice, Hydroxycut), and performance-enhancing products 2.
• Toxicology screen: Ask about recreational drug use, including cocaine, methamphetamine, ecstasy (MDMA), ketamine, and heroin 2.

For Suspected Autoimmune Myositis

• Autoimmune markers: Check ANA, anti-CCP, rheumatoid factor, myositis-specific antibodies, ASMA, and ANCA if autoimmune myositis is suspected 2, 1.
• Viral studies: Consider if viral myositis is clinically indicated 2, 3, 1.

For Recurrent or Unexplained Rhabdomyolysis

• Genetic and metabolic testing: Consider RYR1 and CACNA1S gene sequencing for malignant hyperthermia susceptibility, particularly in patients with exertional rhabdomyolysis or heat illness 2, 1.
• Additional genetic testing: CPT2, PYGM, ACADM, AMPD1, and VLCAD gene testing for metabolic myopathies causing recurrent rhabdomyolysis 2.
• Referral for malignant hyperthermia susceptibility: Consider in cases of exertional rhabdomyolysis, recurrent episodes, or persistently elevated CK with no identified cause after neurological workup 3.

For Metabolic or Hereditary Disorders

• Serum calcium, phosphorus, alkaline phosphatase, parathyroid hormone, and 25-hydroxy-vitamin D if metabolic disorder is suspected 2.

Serial Monitoring During Treatment

Monitoring frequency depends on severity:

Severe Rhabdomyolysis (CK >50,000 IU/L or >15,000 IU/L with complications)

• CK, electrolytes, and renal function every 6-12 hours initially 3, 1. Once CK begins to decrease, reduce to daily monitoring 3.
• Potassium every 6-12 hours in severe cases 1.
• Urine output hourly, with a target of ≥300 mL/hour 1.
• Continue IV fluids typically until CK <1,000 U/L 1.
• Daily renal function monitoring (creatinine and BUN) until stable 1.

Moderate Rhabdomyolysis (CK 15,000-50,000 IU/L)

• Daily CK, electrolytes, and renal function 1.

Mild Rhabdomyolysis (CK <15,000 IU/L with normal renal function)

• Daily CK and basic metabolic panel until CK is declining 1.

Special Considerations and Compartment Syndrome Assessment

In traumatic cases, assess for compartment syndrome:

• Clinical assessment: Monitor for pain, tension, paresthesia, and paresis (early signs) 2, 3. Late signs include pulselessness and pallor, which indicate irreversible damage 2.
• Compartment pressure measurement: Consider fasciotomy when compartment pressure exceeds 30 mmHg or when differential pressure (diastolic blood pressure – compartment pressure) is <30 mmHg 2.
• ECG monitoring: Crucial to detect cardiac arrhythmias, particularly with electrolyte abnormalities 3.

Common Pitfalls to Avoid

• Do not use CK-MB for rhabdomyolysis diagnosis: Check total CK instead, as CK-MB lacks sensitivity and specificity for rhabdomyolysis 2. Use troponin I and troponin T for cardiac injury assessment.
• Do not assume peak CK at initial presentation: CK peaks 24-120 hours after the inciting event 2. If clinical suspicion remains high, repeat CK at 24 hours post-event.
• Impact trauma can elevate CK without true rhabdomyolysis: However, if CK is doubling or trending upward, assume true muscle breakdown until proven otherwise 2.
• Do not wait for the classic triad: Myalgia, weakness, and pigmenturia occur in less than 10% of patients 4. Maintain high clinical suspicion based on mechanism and risk factors.